Physicians Formula (FACE) Issues FY12 Outlook
Physicians Formula (Nasdaq: FACE) sees FY12 EPS of 7-15 cents on sales which are expected to be up 7-10 percent. The Street is currently expecting FY12 EPS of 16 cents.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xerox Corp. (XRX) Tops Q4 EPS by 2c; Guides Q1 EPS Below Expectations; Cuts FY15 EPS Outlook
- Chevron (CVX) Plans 13% Lower Capital Budget for FY15
- IDEXX Labs (IDXX) Misses Q4 EPS Views; Nudges FY15 Outlook Higher
Create E-mail Alert Related CategoriesGuidance
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!